The Use of Medical Grade Honey on Infected Chronic Diabetic Foot Ulcers-A Prospective Case-Control Study
Status Publisher Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
PubMed
37760661
PubMed Central
PMC10525154
DOI
10.3390/antibiotics12091364
PII: antibiotics12091364
Knihovny.cz E-zdroje
- Klíčová slova
- anti-inflammatory treatment, diabetes, diabetic foot ulcer, glycaemia, medical grade honey,
- Publikační typ
- časopisecké články MeSH
Non-healing wounds are usually colonised and contaminated by different types of bacteria. An alternative to antibiotic treatment in patients with infected wounds with local signs of inflammation may be medical grade honey (MGH). MGH has antioxidant, antimicrobial, anti-inflammatory, and immunomodulatory features. This study aims to evaluate the effect of MGH therapy on infected non-healing wounds, especially for diabetic foot syndrome. Prospective, observational case series (n = 5) of patients with wounds of diabetic foot syndrome are presented. There were five males with an average age of 61.6 years. All wounds were treated with MGH, and the healing trajectory was rigorously and objectively monitored. In all cases, there was a gradual disappearance of odour, pain, and exudation. Moreover, the wound areas significantly reduced within 40 days and there was a decrease in glycated haemoglobin and glycaemia values. All these outcomes resulted in improved quality of life of the patients. Despite bacterial colonisation, antibiotic treatment was not necessary. All wounds were completely healed. MGH has antimicrobial, anti-inflammatory, and antioxidant effects in diabetic foot syndrome wounds, does not increase glycated haemoglobin or glycaemia levels, and thus constitutes an effective alternative to the use of antibiotics in the treatment of locally infected wounds.
Department of Health Sciences College of Polytechnics Jihlava 586 01 Jihlava Czech Republic
Department of Health Sciences Faculty of Medicine Masaryk University 625 00 Brno Czech Republic
DiaPodi Care spol s r o 392 01 Soběslav Czech Republic
Triticum Exploitatie BV Sleperweg 44 6222 NK Maastricht The Netherlands
Zobrazit více v PubMed
World Union of Wound Healing Societies (WUWHS) Florence Congress, Position Document. Advance in Wound Care: The Triangle of Wound Assessment. Wounds International; Hatfields, London: 2016.
Pokorna A., Benesova K., Muzik J., Jarkovsky J., Dusek L. Data Sources for Monitoring of Non-healing Wounds in a National Heal Information System—Epidemiology of Non-healing Wounds Analysis of the National Register of Hospitalized Patients in 2007–2015. Cesk. Slov. Neurol. 2017;80:8–17. doi: 10.14735/amcsnn2017S8. DOI
Deufert D., Graml R. Disease-specific, health-related quality of life (HRQoL) of people with chronic wounds—A descriptive cross-sectional study using the Wound-QoL. Wound Med. 2017;16:29–33. doi: 10.1016/j.wndm.2017.01.006. DOI
Krupova L., Pokorna A. Quality of life in patient with non-healing wounds, with particular focus on assesment tools-a literature review. Cent. Eur. J. Nurs. Midwifery. 2020;11:94–103. doi: 10.15452/cejnm.2020.11.0010. DOI
International Best Practice Guidelines: Wound Management in Diabetic Foot Ulcers Wounds International. 2013. [(accessed on 15 June 2023)]. Available online: www.woundsinternational.com.
Zhang P., Lu J., Jing Y., Tang S., Zhu D., Bi Y. Global epidemiology of diabetic foot ulceration: A systematic review and meta-analysis (dagger) Ann. Med. 2017;49:106–116. doi: 10.1080/07853890.2016.1231932. PubMed DOI
Van Acker K., Garoufalis M., Wilson P. POINT: Podiatry for international diabetic foot teams. J. Wound Care. 2018;27((Suppl. S11)):1–32. doi: 10.12968/jowc.2018.27.Sup11.1. PubMed DOI
Lechleitner M., Abrahamian H., Francesconi C., Kofler M., Sturm W., Kohler G. [Diabetic neuropathy and diabetic foot syndrome (Update 2019)] Wien. Klin. Wochenschr. 2019;131:141–150. doi: 10.1007/s00508-019-1487-4. PubMed DOI
Dowsett C., Hallern B. The Triangle of Wound Assessment: A holistic framework from wound assessment to management goals and treatments. Wounds Int. 2017;8:34–39.
Stryja J. [Up-to-Date Approaches to Non-Healing Wound Treatment] Original Title: Moderní postupy v léčbě nehojících se ran. Remedia. 2010;20:180–184.
Fu X.L., Ding H., Miao W.W., Mao C.X., Zhan M.Q., Chen H.L. Global recurrence rates in diabetic foot ulcers: A systematic review and meta-analysis. Diabetes Metab. Res. Rev. 2019;35:e3160. doi: 10.1002/dmrr.3160. PubMed DOI
Dayya D., O’Neill O., Habib N., Moore J., Iyer K., Huedo-Medina T.B. Debridement of diabetic foot ulcers: Public health and clinical implications—A systematic review, meta-analysis, and meta-regression. BMJ Surg. Interv. Health Technol. 2022;4:e000081. doi: 10.1136/bmjsit-2021-000081. PubMed DOI PMC
Cremers N., Belas A., Santos Costa S., Couto I., de Rooster H., Pomba C. In vitro antimicrobial efficacy of two medical grade honey formulations against common high-risk meticillin-resistant staphylococci and Pseudomonas spp. pathogens. Vet. Dermatol. 2020;31:90–96. doi: 10.1111/vde.12811. PubMed DOI
Smaropoulos E., Cremers N.A.J. Treating severe wounds in pediatrics with medical grade honey: A case series. Clin. Case Rep. 2020;8:469–476. doi: 10.1002/ccr3.2691. PubMed DOI PMC
Bianchi T., Wolcott R.D., Peghetti A., Leaper D., Cutting K., Polignano R., Rosa Rita Z., Moscatelli A., Greco A., Romanelli M., et al. Recommendations for the management of biofilm: A consensus document. J. Wound Care. 2016;25:305–317. doi: 10.12968/jowc.2016.25.6.305. PubMed DOI
Nair H.K.R., Tatavilis N., Pospisilova I., Kucerova J., Cremers N.A.J. Medical-Grade Honey Kills Antibiotic-Resistant Bacteria and Prevents Amputation in Diabetics with Infected Ulcers: A Prospective Case Series. Antibiotics. 2020;9:529. doi: 10.3390/antibiotics9090529. PubMed DOI PMC
Mandal M.D., Mandal S. Honey: Its medicinal property and antibacterial activity. Asian Pac. J. Trop. Biomed. 2011;1:154–160. doi: 10.1016/S2221-1691(11)60016-6. PubMed DOI PMC
Mayer A., Slezak V., Takac P., Olejnik J., Majtan J. Treatment of non-healing leg ulcers with honeydew honey. J. Tissue Viability. 2014;23:94–97. doi: 10.1016/j.jtv.2014.08.001. PubMed DOI
Hermanns R., Mateescu C., Thrasyvoulou A., Tananaki C., Wagener F.A., Cremers N.A. Defining the standards for medical grade honey. J. Apic. Res. 2020;59:125–135. doi: 10.1080/00218839.2019.1693713. DOI
Gethin G., Cowman S. Bacteriological changes in sloughy venous leg ulcers treated with manuka honey or hydrogel: An RCT. J. Wound Care. 2008;17:241–244. doi: 10.12968/jowc.2008.17.6.29583. PubMed DOI
Cianciosi D., Forbes-Hernandez T.Y., Afrin S., Gasparrini M., Reboredo-Rodriguez P., Manna P.P., Zhang J., Bravo Lamas L., Martinez Florez S., Agudo Toyos P., et al. Phenolic Compounds in Honey and Their Associated Health Benefits: A Review. Molecules. 2018;23:2322. doi: 10.3390/molecules23092322. PubMed DOI PMC
Combarros-Fuertes P., Fresno J.M., Estevinho M.M., Sousa-Pimenta M., Tornadijo M.E., Estevinho L.M. Honey: Another Alternative in the Fight against Antibiotic-Resistant Bacteria? Antibiotics. 2020;9:774. doi: 10.3390/antibiotics9110774. PubMed DOI PMC
Pleeging C.C.F., Wagener F., de Rooster H., Cremers N.A.J. Revolutionizing non-conventional wound healing using honey by simultaneously targeting multiple molecular mechanisms. Drug Resist. Updates. 2022;62:100834. doi: 10.1016/j.drup.2022.100834. PubMed DOI
Yildiz Karadeniz E., Kaplan Serin E. Use of honey in diabetic foot ulcer: Systematic review and meta-analysis. J. Tissue Viability. 2023;32:270–278. doi: 10.1016/j.jtv.2023.03.002. PubMed DOI
Shukrimi A., Sulaiman A.R., Halim A.Y., Azril A. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers. Med. J. Malays. 2008;63:44–46. PubMed
Labban L. Honey as a promising treatment for diabetic foot ulcers (DFU) J. Med. Soc. 2014;28:64–68. doi: 10.4103/0972-4958.141064. DOI
Molan P.C. Re-introducing honey in the management of wounds and ulcers—Theory and practice. Ostomy Wound Manag. 2002;48:28–40. PubMed
Moore O.A., Smith L.A., Campbell F., Seers K., McQuay H.J., Moore R.A. Systematic review of the use of honey as a wound dressing. BMC Complement. Altern. Med. 2001;1:2. doi: 10.1186/1472-6882-1-2. PubMed DOI PMC
Lusby P.E., Coombes A., Wilkinson J.M. Honey: A potent agent for wound healing? J. Wound Ostomy Cont. Nurs. 2002;29:295–300. doi: 10.1097/00152192-200211000-00008. PubMed DOI
Tsalamandris S., Antonopoulos A.S., Oikonomou E., Papamikroulis G.A., Vogiatzi G., Papaioannou S., Deftereos S., Tousoulis D. The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives. Eur. Cardiol. 2019;14:50–59. doi: 10.15420/ecr.2018.33.1. PubMed DOI PMC
van Niekerk G., Davis T., Patterton H.G., Engelbrecht A.M. How Does Inflammation-Induced Hyperglycemia Cause Mitochondrial Dysfunction in Immune Cells? Bioessays. 2019;41:e1800260. doi: 10.1002/bies.201800260. PubMed DOI
Kirby P., Khan N., Dhillon N., Emmerson E., Fisher A., Thompson J., Burnside J., Chesterton L., Fernando D. Do honey-impregnated dressings affect glycaemic control? Diabet. Foot J. 2009;12:177–180.
Olsson M., Jarbrink K., Divakar U., Bajpai R., Upton Z., Schmidtchen A., Car J. The humanistic and economic burden of chronic wounds: A systematic review. Wound Repair. Regen. 2019;27:114–125. doi: 10.1111/wrr.12683. PubMed DOI
Lu J., Cokcetin N.N., Burke C.M., Turnbull L., Liu M., Carter D.A., Whitchurch C.B., Harry E.J. Honey can inhibit and eliminate biofilms produced by Pseudomonas aeruginosa. Sci. Rep. 2019;9:18160. doi: 10.1038/s41598-019-54576-2. PubMed DOI PMC
Kelechi T., Prentice M., Madisetti M., Brunette G., Mueller M. Palliative Care in the Management of Pain, Odor, and Exudate in Chronic Wounds at the End of Life: A Cohort Study. J. Hosp. Palliat. Nurs. 2017;19:17–25. doi: 10.1097/NJH.0000000000000306. DOI
Bates M. The Future of Wound Care. IEEE Pulse. 2020;11:22–25. doi: 10.1109/MPULS.2020.3008460. PubMed DOI
Nussbaum S.R., Carter M.J., Fife C.E., DaVanzo J., Haught R., Nusgart M., Cartwright D. An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds. Value Health. 2018;21:27–32. doi: 10.1016/j.jval.2017.07.007. PubMed DOI
Al-Gharibi K.A., Sharstha S., Al-Faras M.A. Cost-Effectiveness of Wound Care: A concept analysis. Sultan Qaboos Univ. Med. J. 2018;18:e433–e439. doi: 10.18295/squmj.2018.18.04.002. PubMed DOI PMC
Lindholm C., Searle R. Wound management for the 21st century: Combining effectiveness and efficiency. Int. Wound J. 2016;13((Suppl. S2)):5–15. doi: 10.1111/iwj.12623. PubMed DOI PMC
Biglari B., Moghaddam A., Santos K., Blaser G., Buchler A., Jansen G., Langler A., Graf N., Weiler U., Licht V., et al. Multicentre prospective observational study on professional wound care using honey (Medihoney) Int. Wound J. 2013;10:252–259. doi: 10.1111/j.1742-481X.2012.00970.x. PubMed DOI PMC
Naik P.P., Chrysostomou D., Cinteza M., Pokorna A., Cremers N.A. When time does not heal all wounds-the use of medical grade honey in wound healing: A case series. J. Wound Care. 2022;31:548–558. doi: 10.12968/jowc.2022.31.7.548. PubMed DOI
Papanikolaou G.E., Gousios G., Cremers N.A.J. Use of Medical-Grade Honey to Treat Clinically Infected Heel Pressure Ulcers in High-Risk Patients: A Prospective Case Series. Antibiotics. 2023;12:605. doi: 10.3390/antibiotics12030605. PubMed DOI PMC
Halstead F.D., Webber M.A., Oppenheim B.A. Use of an engineered honey to eradicate preformed biofilms of important wound pathogens: An in vitro study. J. Wound Care. 2017;26:442–450. doi: 10.12968/jowc.2017.26.8.442. PubMed DOI
Wu Y.K., Cheng N.C., Cheng C.M. Biofilms in Chronic Wounds: Pathogenesis and Diagnosis. Trends Biotechnol. 2019;37:505–517. doi: 10.1016/j.tibtech.2018.10.011. PubMed DOI
Goswami A.G., Basu S., Banerjee T., Shukla V.K. Biofilm and wound healing: From bench to bedside. Eur. J. Med. Res. 2023;28:157. doi: 10.1186/s40001-023-01121-7. PubMed DOI PMC
Sen C.K., Roy S., Mathew-Steiner S.S., Gordillo G.M. Biofilm Management in Wound Care. Plast. Reconstr. Surg. 2021;148:275e–288e. doi: 10.1097/PRS.0000000000008142. PubMed DOI PMC
Burmolle M., Thomsen T.R., Fazli M., Dige I., Christensen L., Homoe P., Tvede M., Nyvad B., Tolker-Nielsen T., Givskov M., et al. Biofilms in chronic infections—A matter of opportunity—Monospecies biofilms in multispecies infections. FEMS Immunol. Med. Microbiol. 2010;59:324–336. doi: 10.1111/j.1574-695X.2010.00714.x. PubMed DOI
Alves P.J., Barreto R.T., Barrois B.M., Gryson L.G., Meaume S., Monstrey S.J. Update on the role of antiseptics in the management of chronic wounds with critical colonisation and/or biofilm. Int. Wound J. 2021;18:342–358. doi: 10.1111/iwj.13537. PubMed DOI PMC
Pleeging C.C.F., Coenye T., Mossialos D., de Rooster H., Chrysostomou D., Wagener F., Cremers N.A.J. Synergistic Antimicrobial Activity of Supplemented Medical-Grade Honey against Pseudomonas aeruginosa Biofilm Formation and Eradication. Antibiotics. 2020;9:866. doi: 10.3390/antibiotics9120866. PubMed DOI PMC
Smaropoulos E., Cremers N.A.J. The pro-healing effects of medical grade honey supported by a pediatric case series. Complement. Ther. Med. 2019;45:14–18. doi: 10.1016/j.ctim.2019.05.014. PubMed DOI
de Groot T., Janssen T., Faro D., Cremers N.A.J., Chowdhary A., Meis J.F. Antifungal Activity of a Medical-Grade Honey Formulation against Candida auris. J. Fungi. 2021;7:50. doi: 10.3390/jof7010050. PubMed DOI PMC
Bocoum A., Riel S., Traore S.O., Ngo Oum Ii E.F., Traore Y., Thera A.T., Fane S., Dembele B.T., Cremers N.A.J. Medical-Grade Honey Enhances the Healing of Caesarean Section Wounds and Is Similarly Effective to Antibiotics Combined with Povidone-Iodine in the Prevention of Infections-A Prospective Cohort Study. Antibiotics. 2023;12:92. doi: 10.3390/antibiotics12010092. PubMed DOI PMC
Holubova A., Chlupacova L., Cetlova L., Cremers N.A.J., Pokorna A. Medical-Grade Honey as an Alternative Treatment for Antibiotics in Non-Healing Wounds-A Prospective Case Series. Antibiotics. 2021;10:918. doi: 10.3390/antibiotics10080918. PubMed DOI PMC
Smaropoulos E., Cremers N.A. Medical grade honey for the treatment of paediatric abdominal wounds: A case series. J. Wound Care. 2020;29:94–99. doi: 10.12968/jowc.2020.29.2.94. PubMed DOI
Sochor M., Slama O. [Management of chronic and acute pain in patients with cancer diseases] Klin. Onkol. 2015;28:94–98. doi: 10.14735/amko201594. PubMed DOI
Juric Vukelic D., Juric J. Hydrocolloid Dressing Application in the Treatment of Chronic Wounds and Relation to Quality of Life. Acta Clin. Croat. 2017;56:544–549. doi: 10.20471/acc.2017.56.03.22. PubMed DOI
Rosenbaum C. An overview of integrative care options for patients with chronic wounds. Ostomy Wound Manag. 2012;58:44–51. PubMed
Edwards J. Dealing with wound-related pain at dressing change. J. Community Nurs. 2013;27:36–42.
Upton D., Solowiej K., Hender C., Woodyatt K.Y. Stress and pain associated with dressing change in patients with chronic wounds. J. Wound Care. 2012;21:53–54. doi: 10.12968/jowc.2012.21.2.53. PubMed DOI
Zelenikova R., Vyhlidalova D. Applying honey dressings to non-healing wounds in elderly persons receiving home care. J. Tissue Viability. 2019;28:139–143. doi: 10.1016/j.jtv.2019.04.002. PubMed DOI
Ousey K., Roberts D., Gefen A. Early identification of wound infection: Understanding wound odour. J. Wound Care. 2017;26:577–582. doi: 10.12968/jowc.2017.26.10.577. PubMed DOI
Alam F., Islam M.A., Gan S.H., Khalil M.I. Honey: A potential therapeutic agent for managing diabetic wounds. Evid. Based Complement. Altern. Med. 2014;2014:169130. doi: 10.1155/2014/169130. PubMed DOI PMC
Yapucu Gunes U., Eser I. Effectiveness of a honey dressing for healing pressure ulcers. J. Wound Ostomy Cont. Nurs. 2007;34:184–190. doi: 10.1097/01.WON.0000264833.11108.35. PubMed DOI